Retraction: Identification of an immunologic signature of lung adenocarcinomas based on genome-wide immune expression profiles
- 1College of Pharmacy, Youjiang Medical University for Nationalities, Baise, China
- 2Medical College of Guangxi University, Nanning, China
- 3Key Laboratory of High Incidence of Disease Prevention in the West of Guangxi, Youjiang Medical University for Nationalities, Baise, China
Citation: Ling B, Ye G, Zhao Q, Jiang Y, Liang L and Tang Q (2021) Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles. Front. Mol. Biosci. 7:603701. doi: 10.3389/fmolb.2020.603701
Received: 07 September 2020; Accepted: 03 December 2020;
Published: 11 January 2021; Retracted: 31 July 2024.
Edited by:
Mahendra Pratap Kashyap, University of Alabama at Birmingham, United StatesReviewed by:
Rakesh Pathak, National Institutes of Health Clinical Center (NIH), United StatesRanganatha R. Somasagara, North Carolina Central University, United States